| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 81.28B | 80.24B | 72.22B | 79.43B | 80.52B | 70.57B |
| Gross Profit | 16.94B | 16.09B | 11.68B | 11.57B | 17.97B | 16.69B |
| EBITDA | 7.49B | 9.00B | 4.76B | 49.00M | 6.29B | 7.14B |
| Net Income | 1.73B | 2.64B | -1.04B | -4.94B | 1.50B | 2.17B |
Balance Sheet | ||||||
| Total Assets | 121.26B | 122.30B | 125.42B | 119.03B | 117.74B | 105.76B |
| Cash, Cash Equivalents and Short-Term Investments | 9.07B | 9.43B | 11.58B | 11.14B | 10.37B | 8.46B |
| Total Debt | 40.27B | 39.38B | 42.68B | 35.27B | 26.76B | 21.99B |
| Total Liabilities | 64.57B | 65.06B | 68.50B | 62.53B | 55.16B | 47.17B |
| Stockholders Equity | 58.57B | 58.47B | 56.13B | 54.08B | 59.18B | 57.23B |
Cash Flow | ||||||
| Free Cash Flow | -1.52B | 712.00M | -5.70B | -6.69B | -2.43B | -2.34B |
| Operating Cash Flow | 2.97B | 5.12B | 1.16B | -575.00M | 3.99B | 3.69B |
| Investing Cash Flow | -3.46B | -3.24B | -7.14B | -6.05B | -7.40B | -7.30B |
| Financing Cash Flow | -1.12B | -4.70B | 5.48B | 6.67B | 4.93B | 1.35B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥32.41B | 14.61 | ― | 2.47% | 3.53% | 8.36% | |
75 Outperform | ¥51.88B | 19.10 | ― | 1.92% | -0.86% | 17.65% | |
66 Neutral | ¥28.74B | 12.65 | ― | 3.84% | -3.41% | -12.83% | |
66 Neutral | ¥24.76B | 12.97 | ― | 4.62% | 7.19% | ― | |
65 Neutral | ¥37.20B | 19.44 | ― | 2.37% | -11.70% | -54.82% | |
64 Neutral | ¥26.09B | 15.04 | ― | 4.27% | 5.72% | 28.92% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
Arakawa Chemical Industries reported a 2.6% increase in net sales for the six months ending September 30, 2025, compared to the previous year. Despite the rise in sales, the profit attributable to owners of the parent decreased by 55.7%, indicating challenges in maintaining profitability. The company forecasts a 5.9% increase in net sales for the fiscal year ending March 31, 2026, with a significant expected rise in operating and ordinary profits, suggesting a strategic focus on improving operational efficiency.
The most recent analyst rating on (JP:4968) stock is a Hold with a Yen1207.00 price target. To see the full list of analyst forecasts on Arakawa Chemical Industries,Ltd. stock, see the JP:4968 Stock Forecast page.